Fusion Antibodies
GBX13.68
3
-GBX0.57-4% Today
Statistics
Day High
15
Day Low
13.68
52W High
19.25
52W Low
5.8
Volume
1,929,728
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
3JunExpected
Expected EPS
N/A
Actual EPS
N/A
Financials
-87.18%Profit Margin
Unprofitable196.5MRevenue
-171.3MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow FAB.LSE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap79.46B
Astrazeneca
AZN.LSE
Mkt Cap216.43B
Repligen
RGEN
Mkt Cap6.67B
Summit Therapeutics
SMMT
Mkt Cap17.14B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.28B
Immunic
IMUX
Mkt Cap11.99M
CRISPR Therapeutics
CRSP
Mkt Cap4.7B
About
Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally. The company offers monoclonal antibody discovery and development, antibody sequencing, antibody engineering, antibody humanization and rational affinity maturation platform, recombinant protein expression, and stable cell line development and cGMP scale up services. It serves pharmaceutical, biotech, veterinary, diagnostic, and life science research companies. The company has a collaboration agreement with the National Cancer Institute for the use of OptiMAL. Fusion Antibodies plc was incorporated in 2000 and is based in Belfast, the United Kingdom.
Show more...
CEO
Dr. Adrian Robert Kinkaid Ph.D.
Employees
24
Country
United Kingdom
ISIN
GB00BDQZGK16
Listings
0 Comments
Share your thoughts
FAQ
What is Fusion Antibodies stock price today?▼
The current price of FAB.LSE is GBX13.68 GBX — it has decreased by -4% in the past 24 hours. Watch Fusion Antibodies stock price performance more closely on the chart.
What is Fusion Antibodies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Fusion Antibodies stocks are traded under the ticker FAB.LSE.
Is Fusion Antibodies stock price growing?▼
FAB.LSE stock has fallen by -3.66% compared to the previous week, the month change is a +7.29% rise, over the last year Fusion Antibodies has showed a +96.83% increase.
When is the next Fusion Antibodies earnings date?▼
Fusion Antibodies is going to release the next earnings report on June 03, 2026.
What were Fusion Antibodies earnings last quarter?▼
FAB.LSE earnings for the last quarter are -0.51 GBX per share, whereas the estimation was N/A GBX resulting in a N/A surprise. The estimated earnings for the next quarter are N/A GBX per share.
What is Fusion Antibodies revenue for the last year?▼
Fusion Antibodies revenue for the last year amounts to 196.5M GBX.
What is Fusion Antibodies net income for the last year?▼
FAB.LSE net income for the last year is -171.3M GBX.
How many employees does Fusion Antibodies have?▼
As of April 29, 2026, the company has 24 employees.
In which sector is Fusion Antibodies located?▼
Fusion Antibodies operates in the Health & Wellness sector.
When did Fusion Antibodies complete a stock split?▼
Fusion Antibodies has not had any recent stock splits.
Where is Fusion Antibodies headquartered?▼
Fusion Antibodies is headquartered in Belfast, United Kingdom.